Literature DB >> 12401455

Muscle MRI findings in a three-generation family affected by Bethlem myopathy.

Eugenio Mercuri1, Claudio Cini, Serena Counsell, Joanna Allsop, Zuella Zolkipli, Heinz Jungbluth, Caroline Sewry, Susan C Brown, Guglielmina Pepe, Francesco Muntoni.   

Abstract

We report clinical and muscle magnetic resonance imaging (MRI) findings in three individuals (aged 6, 26 and 73 years) from a three-generation family with Bethlem myopathy, confirmed by molecular genetic analysis which showed an exon skipping mutation in the COL6A1 gene. The clinical severity ranged from mild proximal weakness and distal laxity in the younger patients, to inability to stand or walk and severe contractures in the 76-year-old grandmother. The pattern of muscle involvement showed variable severity in parallel with the severity of motor function impairment. Although there was a marked variability in the severity of the MRI findings, it was possible to recognize a specific pattern of muscle involvement in all three patients. This consisted of involvement of the peripheral region of the vastus lateralis and hamstrings muscles with relative sparing of their central part. This was best appreciated in the third decade of life, but could also be identified both in the younger patient with minimal MRI changes and in the oldest patient, despite her more severe and diffuse muscle involvement. This report suggests that muscle MRI could be used as an additional tool to establish the pattern and the degree of muscle involvement in patients with Bethlem myopathy. Further studies in a larger cohort are needed to evaluate the specificity of these findings.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12401455     DOI: 10.1016/s1090-3798(02)90618-5

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  13 in total

1.  Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies.

Authors:  Stojan Peric; Ruzica Maksimovic; Bojan Banko; Milica Durdic; Bogdan Bjelica; Ivo Bozovic; Yunus Balcik; Jovan Pesovic; Dusanka Savic-Pavicevic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2017-07-29       Impact factor: 4.849

Review 2.  Collagen VI related muscle disorders.

Authors:  A K Lampe; K M D Bushby
Journal:  J Med Genet       Date:  2005-09       Impact factor: 6.318

3.  Magnetic resonance imaging, ultrasound and real-time ultrasound elastography of the thigh muscles in congenital muscle dystrophy.

Authors:  Eleni E Drakonaki; Gina M Allen
Journal:  Skeletal Radiol       Date:  2010-04       Impact factor: 2.199

4.  Bioimpedance Analysis as a Method to Evaluate the Proportion of Fatty and Muscle Tissues in Progressive Myopathy in Pompe Disease.

Authors:  Agnieszka Różdżyńska-Świątkowska; Elżbieta Jurkiewicz; Anna Tylki-Szymańska
Journal:  JIMD Rep       Date:  2015-08-08

5.  Flow cytometry analysis: a quantitative method for collagen VI deficiency screening.

Authors:  J Kim; C Jimenez-Mallebrera; A R Foley; M Fernandez-Fuente; S C Brown; S Torelli; L Feng; C A Sewry; F Muntoni
Journal:  Neuromuscul Disord       Date:  2011-11-08       Impact factor: 4.296

6.  Muscle magnetic resonance imaging in congenital myasthenic syndromes.

Authors:  Sarah Finlayson; Jasper M Morrow; Pedro M Rodriguez Cruz; Christopher D J Sinclair; Arne Fischmann; John S Thornton; Steve Knight; Ray Norbury; Mel White; Michal Al-Hajjar; Nicola Carboni; Sandeep Jayawant; Stephanie A Robb; Tarek A Yousry; David Beeson; Jacqueline Palace
Journal:  Muscle Nerve       Date:  2016-02-22       Impact factor: 3.217

7.  Pilot phenotype and natural history study of hereditary neuropathies caused by mutations in the HSPB1 gene.

Authors:  Alexander M Rossor; Jasper M Morrow; James M Polke; Sinead M Murphy; Henry Houlden; Matilde Laura; Hadi Manji; Julian Blake; Mary M Reilly
Journal:  Neuromuscul Disord       Date:  2016-10-08       Impact factor: 4.296

8.  Clinical and molecular findings in a cohort of ANO5-related myopathy.

Authors:  André M S Silva; Antônio R Coimbra-Neto; Paulo Victor S Souza; Pablo B Winckler; Marcus V M Gonçalves; Eduardo B U Cavalcanti; Alzira A D S Carvalho; Cláudia F D R Sobreira; Clara G Camelo; Rodrigo D H Mendonça; Eduardo D P Estephan; Umbertina C Reed; Marcela C Machado-Costa; Mario E T Dourado-Junior; Vanessa C Pereira; Marcelo M Cruzeiro; Paulo V P Helito; Laís U Aivazoglou; Leonardo V D Camargo; Hudson H Gomes; Amaro J S D Camargo; Wladimir B V D R Pinto; Bruno M L Badia; Luiz H Libardi; Mario T Yanagiura; Acary S B Oliveira; Anamarli Nucci; Jonas A M Saute; Marcondes C França-Junior; Edmar Zanoteli
Journal:  Ann Clin Transl Neurol       Date:  2019-06-11       Impact factor: 4.511

9.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.

Authors:  Maria Kinali; Virginia Arechavala-Gomeza; Lucy Feng; Sebahattin Cirak; David Hunt; Carl Adkin; Michela Guglieri; Emma Ashton; Stephen Abbs; Petros Nihoyannopoulos; Maria Elena Garralda; Mary Rutherford; Caroline McCulley; Linda Popplewell; Ian R Graham; George Dickson; Matthew J A Wood; Dominic J Wells; Steve D Wilton; Ryszard Kole; Volker Straub; Kate Bushby; Caroline Sewry; Jennifer E Morgan; Francesco Muntoni
Journal:  Lancet Neurol       Date:  2009-08-25       Impact factor: 44.182

10.  Diagnostic approach to the congenital muscular dystrophies.

Authors:  Carsten G Bönnemann; Ching H Wang; Susana Quijano-Roy; Nicolas Deconinck; Enrico Bertini; Ana Ferreiro; Francesco Muntoni; Caroline Sewry; Christophe Béroud; Katherine D Mathews; Steven A Moore; Jonathan Bellini; Anne Rutkowski; Kathryn N North
Journal:  Neuromuscul Disord       Date:  2014-01-09       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.